The historical rank and industry rank for Cytokinetics's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Cytokinetics's highest Price to Tangible Book Ratio was 15.85. The lowest was 3.36. And the median was 6.04.
CYTK's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.65 * Ranked among companies with meaningful Price-to-Tangible-Book only.
Cytokinetics Price-to-Tangible-Book Historical Data
The historical data trend for Cytokinetics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cytokinetics's Price-to-Tangible-Book
For the Biotechnology subindustry, Cytokinetics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cytokinetics's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cytokinetics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Cytokinetics's Price-to-Tangible-Book falls into.
Cytokinetics Price-to-Tangible-Book Calculation
Cytokinetics's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Cytokinetics Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Cytokinetics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CYTK has been successfully added to your 